http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013132085-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2013132085-A |
| titleOfInvention | METHOD FOR TREATING PATIENTS WITH RHEUMATOID ARTHRITIS |
| abstract | A method of treating patients with rheumatoid arthritis, including the simultaneous combined use of drugs and laser therapy, characterized in that methotrexate is used subcutaneously as a basic anti-inflammatory drug at a dose of 15 mg once a week, and folic acid inside is administered at a dose of 5 mg per week, additionally prescribed moval intramuscularly at a dose of 15 mg once a day, laser therapy is prescribed differentially, depending on the degree of activity of the disease, the severity of endothelial dysfunction, namely von Willebrand factor, the level of indicators of the activity of the hemostatic system, namely the level of activated partial thromboplastin time, prothrombin time, thrombin time, antithrombin III, protein C, with degree I of disease activity, the level of activated partial thromboplastin time equal to and more than 30.6 ± 1 , 5 s, prothrombin time equal to and more than 19.2 ± 0.9 s, thrombin time equal to and more than 15.1 ± 0.7 s, antithrombin III equal to and more than 92.8 ± 7.6%, protein C (BUT), equal to and more than 0.92 ± 0.02, von Willebrand factor, equal and less than 108.9 ± 9.6%, 6-8 daily procedures of intravenous laser blood irradiation are carried out on the first day for 15 minutes at a wavelength of 0.365 microns, the next day for 5 minutes at a wavelength of 0.405 microns, radiation power at the end optical fiber 1.5-2.0 mW, in continuous radiation mode, the procedures alternate every other day, at the II and III degree of disease activity, the level of activated partial thromboplastin time equal to and less than 22.2 ± 5.5 s, prothrombin time equal to and less than 12.8 ± 1.7 s, thrombin time equal to and less than 11.2 ± 0.9 s, antithrom |
| priorityDate | 2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.